UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063703
Receipt number R000068409
Scientific Title Effect of the Time from Syringe Blood Collection to Aliquoting into Vacutainer Tubes on Coagulation Parameters
Date of disclosure of the study information 2026/11/20
Last modified on 2026/11/19 22:20:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of the Order and Timing of Blood Transfer into Collection Tubes on Blood Coagulation Test Results

Acronym

Blood Draw Timing and Coagulation Test Study

Scientific Title

Effect of the Time from Syringe Blood Collection to Aliquoting into Vacutainer Tubes on Coagulation Parameters

Scientific Title:Acronym

Study on Dispensing Order and Blood Coagulation Tests

Region

Japan


Condition

Condition

healthy adult

Classification by specialty

Nursing Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine how time differences arising from the order in which blood is transferred from a syringe into collection tubes affect blood coagulation test results.

Basic objectives2

Others

Basic objectives -Others

the reliability and accuracy of test results

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in PT, APTT, fibrinogen, and related coagulation parameters associated with the time elapsed before aliquoting blood after collection.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male

Key inclusion criteria

Medication free healthy adult men aged 20 years or older and under 40 years.

Key exclusion criteria

1) Individuals with a history of vasovagal reflex during blood collection
2) Individuals who are unable to follow instructions

Target sample size

21


Research contact person

Name of lead principal investigator

1st name Seira
Middle name
Last name Ichinohe

Organization

Aomori University of Health and Welfare, Japan

Division name

Faculty of health science, Department of nursing

Zip code

030-8505

Address

58-1 Mase Hamadate Aomori, Japan

TEL

017-765-2054

Email

s_ichinohe@ms.auhw.ac.jp


Public contact

Name of contact person

1st name Seira
Middle name
Last name Ichinohe

Organization

Aomori University of Health and Welfare, Japan

Division name

Faculty of health science, Department of nursing

Zip code

030-8505

Address

58-1 Mase Hamadate Aomori, Japan

TEL

017-765-2054

Homepage URL


Email

s_ichinohe@ms.auhw.ac.jp


Sponsor or person

Institute

Aomori University of Health and Welfare, Japan

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Aomori University of Health and Welfare

Address

58-1 Mase Hamadate Aomori,Japan

Tel

017-765-2000

Email

auhw_rinri@ms.auhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

青森県立保健大学(青森県)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

21

Results

Data from 21 participants were analyzed. One-way repeated-measures ANOVA showed a significant main effect of blood collection tube for PT (p = 0.012, partial eta squared = 0.15) and FIB (p < 0.001, partial eta squared = 0.21). Dunnett's test found no statistically significant differences between the reference tube and any of the four comparison tubes for any of the four outcomes.

Results date posted

2026 Year 11 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The study included 21 participants. Their age was 27.9 +/- 8.5 years, height was 173.8 +/- 5.4 cm, body weight was 70.3 +/- 9.8 kg, and body mass index (BMI) was 23.4 +/- 3.3 kg/m^2. Values are presented as mean +/- standard deviation.

Participant flow

A total of 21 participants were enrolled. Blood collection and measurements were completed for all 21 participants using the reference blood collection tube and each of the four comparison tubes (1-4). All 21 participants were included in the analysis.

Adverse events

No adverse events were observed in any of the 21 participants during blood collection or during the observation period after blood collection.

Outcome measures

Measurements are reported as mean +/- standard deviation in the following order: reference blood collection tube, followed by comparison tubes 1, 2, 3, and 4. Mean differences were calculated as the comparison tube value minus the reference tube value. The 95% confidence intervals (CIs) and p values from Dunnett's multiple comparisons test are reported.

1. APTT (seconds)
Measurements: 29.1 +/- 2.7, 29.1 +/- 2.6, 29.3 +/- 2.6, 29.1 +/- 2.6, and 29.1 +/- 2.7.
A one-way repeated-measures ANOVA with the Greenhouse-Geisser correction (correction factor = 0.73) showed no statistically significant main effect of tube type (p = 0.089, partial eta squared = 0.10).
Mean differences from the reference tube (exploratory analysis):
Tube 1: 0.0 (95% CI [-0.2, 0.1]), p = 1.00
Tube 2: 0.1 (95% CI [-0.01, 0.3]), p = 0.10
Tube 3: 0.0 (95% CI [-0.2, 0.2]), p = 1.00
Tube 4: 0.0 (95% CI [-0.2, 0.2]), p = 1.00

2. PT (seconds)
Measurements: 10.4 +/- 0.5, 10.4 +/- 0.5, 10.4 +/- 0.4, 10.4 +/- 0.5, and 10.3 +/- 0.4.
A one-way repeated-measures ANOVA assuming sphericity showed a statistically significant main effect of tube type (p = 0.012, partial eta squared = 0.15).
Mean differences from the reference tube:
Tube 1: 0.0 (95% CI [-0.1, 0.1]), p = 1.00
Tube 2: 0.0 (95% CI [-0.1, 0.1]), p = 1.00
Tube 3: 0.1 (95% CI [-0.03, 0.1]), p = 0.30
Tube 4: -0.1 (95% CI [-0.1, 0.02]), p = 0.20

3. PT-INR
Measurements: 0.99 +/- 0.06, 0.99 +/- 0.05, 1.00 +/- 0.03, 1.00 +/- 0.06, and 0.99 +/- 0.05.
A one-way repeated-measures ANOVA assuming sphericity showed no statistically significant main effect of tube type (p = 0.529, partial eta squared = 0.04).
Mean differences from the reference tube (exploratory analysis):
Tube 1: 0.00 (95% CI [-0.02, 0.02]), p = 1.00
Tube 2: 0.01 (95% CI [-0.01, 0.03]), p = 0.70
Tube 3: 0.01 (95% CI [-0.02, 0.03]), p = 0.90
Tube 4: -0.01 (95% CI [-0.03, 0.02]), p = 0.90

4. FIB (mg/dL)
Measurements: 233.1 +/- 31.0, 233.9 +/- 32.0, 234.6 +/- 31.3, 230.4 +/- 31.0, and 231.10 +/- 31.8.
A one-way repeated-measures ANOVA assuming sphericity showed a statistically significant main effect of tube type (p < 0.001, partial eta squared = 0.21).
Mean differences from the reference tube:
Tube 1: 0.9 (95% CI [-1.9, 3.6]), p = 0.90
Tube 2: 1.6 (95% CI [-1.2, 4.3]), p = 0.40
Tube 3: -2.6 (95% CI [-5.4, 0.1]), p = 0.10
Tube 4: -2.0 (95% CI [-4.7, 0.8]), p = 0.2

For all four outcomes, Dunnett's multiple comparisons test found no statistically significant differences between the reference tube and any of the four comparison tubes.

Plan to share IPD

Undecided.

IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 08 Month 21 Day

Date of IRB

2025 Year 08 Month 04 Day

Anticipated trial start date

2025 Year 08 Month 21 Day

Last follow-up date

2026 Year 01 Month 15 Day

Date of closure to data entry

2026 Year 03 Month 09 Day

Date trial data considered complete

2026 Year 03 Month 30 Day

Date analysis concluded

2026 Year 09 Month 28 Day


Other

Other related information

From August 5, 2025, to January 8, 2026, 21 healthy adult men were recruited through posters displayed on the campus of Aomori University of Health and Welfare. For each participant, APTT, PT, PT-INR, and FIB were compared across blood samples collected using the reference blood collection tube and four types of comparison tubes


Management information

Registered date

2026 Year 11 Month 19 Day

Last modified on

2026 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068409